This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Dhanir Tailor: Innovator in Cancer Treatment
Introduction
Dhanir Tailor is a notable inventor based in Palo Alto, CA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on overcoming treatment resistance in cancer, which is a critical challenge in oncology.
Latest Patents
Dhanir Tailor holds a patent for "N-hydroxyethyl didehydroazapodophyllotoxins as GBP1 inhibitors and methods of overcoming treatment resistance in cancer." This patent describes compounds, compositions, and methods for inhibiting GBP1, a protein that plays a role in cancer cell survival. The subject inhibitor compounds can act by inhibiting GBP1 alone and/or GBP1: pro-survival kinase interactions, such as those with serine/threonine-protein kinase pim-1 (PIM1). The methods include contacting a cellular sample with a GBP1 inhibitor to inhibit GBP1 and its interactions, providing new avenues for treating cancer, particularly in cases resistant to chemotherapy and radiation therapy. Dhanir Tailor has 1 patent to his name.
Career Highlights
Dhanir Tailor is affiliated with Leland Stanford Junior University, where he continues to advance his research in cancer therapies. His work is pivotal in developing new strategies to combat cancer treatment resistance, which is a significant hurdle in effective cancer care.
Collaborations
Dhanir Tailor collaborates with esteemed colleagues such as Sanjay Malhotra and Vineet Kumar, contributing to a dynamic research environment focused on innovative cancer treatments.
Conclusion
Dhanir Tailor's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his commitment to advancing medical science. His work is essential in the ongoing battle against cancer, particularly in addressing treatment resistance.